ImmuONE Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 22

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $761K

  • Investors
  • 8

ImmuONE General Information

Description

Operator of a biotech company intended for in vitro cell culture services for safety assessment. The company specializes in human alveolar macrophage responses, epithelial cell culture platforms, and testing services and also offers respiratory tissue models that closely resemble lung physiology to provide relevant, reliable, and reproducible results, enabling healthcare providers to innovate in vitro products and testing services for inhalation safety assessment using state-of-the-art techniques.

Contact Information

Website
www.immuone.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Sycamore House, 16 Leyden Road
  • Hertfordshire
  • Stevenage SG1 2BP
  • England, United Kingdom
+44 01908
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Vertical(s)
Life Sciences
Corporate Office
  • Sycamore House, 16 Leyden Road
  • Hertfordshire
  • Stevenage SG1 2BP
  • England, United Kingdom
+44 01908

ImmuONE Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ImmuONE Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 13-Mar-2025 $761K Completed Generating Revenue
7. Seed Round 25-Oct-2023 Completed Generating Revenue
6. Grant 01-Jan-2021 Completed Startup
5. Angel (individual) 05-May-2020 Completed Startup
4. Grant 31-Oct-2019 Completed Startup
3. Accelerator/Incubator 01-Sep-2018 Completed Startup
2. Accelerator/Incubator Completed Startup
1. University Spin-Out 01-Sep-2018 Completed Startup
To view ImmuONE’s complete valuation and funding history, request access »

ImmuONE Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
A Ordinary
Ordinary
To view ImmuONE’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

ImmuONE Patents

  • 2

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 2

    Pending

  • Expiring in next 12 mo

ImmuONE Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4133053-A1 Method and apparatus for three dimensional alveolar lung model Pending 07-Apr-2020
US-20230158068-A1 Method and apparatus for three dimensional alveolar lung model Pending 07-Apr-2020

ImmuONE Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ImmuONE Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Mercia Ventures Venture Capital Minority
Midlands Engine Investments Venture Capital Minority
Pioneer Group Venture Capital Minority
NC3Rs Government
Innovate UK Government
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial

ImmuONE FAQs

  • When was ImmuONE founded?

    ImmuONE was founded in 2019.

  • Where is ImmuONE headquartered?

    ImmuONE is headquartered in Stevenage, United Kingdom.

  • What is the size of ImmuONE?

    ImmuONE has 22 total employees.

  • What industry is ImmuONE in?

    ImmuONE’s primary industry is Biotechnology.

  • Is ImmuONE a private or public company?

    ImmuONE is a Private company.

  • What is ImmuONE’s current revenue?

    The current revenue for ImmuONE is .

  • How much funding has ImmuONE raised over time?

    ImmuONE has raised $3.38M.

  • Who are ImmuONE’s investors?

    Mercia Ventures, Midlands Engine Investments, Pioneer Group, NC3Rs, and Innovate UK are 5 of 8 investors who have invested in ImmuONE.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process